According to Oragenics's latest financial reports and stock price the company's current Operating Margin is -18,062.00%. At the end of 2021 the company had an Operating Margin of -18,062.03%.
Year | Operating Margin | Change |
---|---|---|
2021 | -18,062.03% | |
2015 | -996.00% | 61.7% |
2014 | -615.95% | -60.43% |
2013 | -1,556.70% | 58.37% |
2012 | -982.94% | 84.9% |
2011 | -531.61% | -18.51% |
2010 | -652.34% | -24.21% |
2009 | -860.67% | -66.62% |
2008 | -2,578.47% | 48.45% |
2007 | -1,736.98% | -60.85% |
2006 | -4,436.23% | |
2004 | -1,592.55% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 22.88% | -100.13% | ๐บ๐ธ USA |
SIGA Technologies SIGA | 66.81% | -100.37% | ๐บ๐ธ USA |
OPKO Health
OPK | -36.36% | -99.80% | ๐บ๐ธ USA |
Nature's Sunshine Products NATR | 7.16% | -100.04% | ๐บ๐ธ USA |
USANA USNA | 14.38% | -100.08% | ๐บ๐ธ USA |
Lannett Company LCI | -43.36% | -99.76% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.